Giorgione Veronica, Bhide Amar, Bhate Rohan, Reed Keith, Khalil Asma
Twins Trust Centre for Research and Clinical Excellence, St George's University Hospitals NHS Foundation Trust, London SW17 0RE, UK.
Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London SW17 0RE, UK.
J Clin Med. 2020 Oct 13;9(10):3276. doi: 10.3390/jcm9103276.
Studies have reported controversial findings on the association between fetal growth restriction (FGR) or intertwin weight discordance and the risk of hypertensive disorders of pregnancy (HDP) in twin pregnancies. The aim of this study was to investigate the association between twin growth disorders and HDP. Twin pregnancies resulting in two live births at St George's Hospital between 2000 and 2019 were included. FGR or small-for-gestational-age (SGA) at birth was assessed using singleton and twin reference charts. Intertwin discordance [(large birthweight - small birthweight)/(large birthweight) × 100%)] was calculated. Logistic regression models were performed. SGA (aOR 2.34, 95% CI 1.60-3.44, < 0.001), intertwin discordance ≥25% (aOR 2.10, 95% CI 1.26-3.49, = 0.004) and their co-existence (aOR 2.03, 95% CI 1.16-3.54, = 0.013) were significantly associated with HDP. After adjusting for the known maternal risk factors of HDP and the intertwin discordance, SGA (using the twin charts) was the strongest independent risk factor associated with HDP (aOR 2.12, 95% CI 1.40-3.22, < 0.001) and preeclampsia (aOR 2.34, 95% CI 1.45-3.76, < 0.001). This study highlights that the presence of at least one SGA twin is significantly associated with HDP during pregnancy. Therefore, maternal blood pressure should be closely monitored in twin pregnancies complicated by SGA with or without intertwin discordance.
关于双胎妊娠中胎儿生长受限(FGR)或双胎体重不一致与妊娠期高血压疾病(HDP)风险之间的关联,研究报告了相互矛盾的结果。本研究的目的是调查双胎生长障碍与HDP之间的关联。纳入了2000年至2019年期间在圣乔治医院分娩的双胎妊娠且分娩两个活产儿的病例。使用单胎和双胎参考图表评估出生时的FGR或小于胎龄儿(SGA)。计算双胎不一致性[(大出生体重 - 小出生体重)/(大出生体重)×100%]。进行逻辑回归模型分析。SGA(调整后比值比[aOR] 2.34,95%置信区间[CI] 1.60 - 3.44,P < 0.001)、双胎不一致性≥25%(aOR 2.10,95% CI 1.26 - 3.49,P = 0.004)以及它们的共存(aOR 2.03,95% CI 1.16 - 3.54,P = 0.013)与HDP显著相关。在调整已知的HDP母体危险因素和双胎不一致性后,SGA(使用双胎图表)是与HDP(aOR 2.12,95% CI 1.40 - 3.22,P < 0.001)和子痫前期(aOR 2.34,95% CI 1.45 - 3.76,P < 0.001)相关的最强独立危险因素。本研究强调,至少有一个SGA双胎与妊娠期HDP显著相关。因此,对于合并有或无双胎不一致性的SGA双胎妊娠,应密切监测母体血压。